Functional Skills
Business Development
Commercial Due Diligence
Customer Segmentation
Data Collection / Research
Financial Modeling
Go-to-market Strategy
Innovation Management
Market Penetration
Operations Management
Sales and Operations Planning (S&OP)
Strategic Planning
Strategy Development
Value Propositions Development
Change Management / Org Design
Commercial Strategy
Software Skills
Microsoft Office
PowerBI
Salesforce
Tableau
Microsoft PowerPoint
Microsoft Excel
Sector Experience
Chemicals
Healthcare
Life Sciences & Pharma
Manufacturing
Technology
Languages
English
Top Consulting Firms
Experience
MILLIPORESIGMA (Life Science Division of Merck KGaA, Germany)
Product Management / Strategy
Sr. Director, Strategy & Marketing, Diagnostics & Regulated Materials
1/2021 - 1/2023
• Leading organization of 15 (9 directs) driving strategy, marketing planning, and global marketing campaign execution to drive >8% growth for >600M€ franchise
• Formulated Molecular Dx growth strategy; achieved board-level approval for CAPEX (>100M€), inorganic roadmap, and creation of new business unit with focus on manufacturing customers
• Formulated Molecular Dx growth strategy; achieved board-level approval for CAPEX (>100M€), inorganic roadmap, and creation of new business unit with focus on manufacturing customers
MILLIPORESIGMA (Life Science Division of Merck KGaA, Germany)
Marketing
Head of Customer Segment Marketing, Emerging Biotech & Diagnostics Manufacturers
1/2016 - 1/2021
• Led team (6 directs) to define market segment strategy, GTM, and innovation priorities for $400M business resulting in sustained growth (+8-13% p.a.)
• Developed and launched digital customer collaboration portal to ~200 Dx manufacturers redefining sales & customer interaction model for supply of critical raw materials (ongoing)
• Created market positioning for emerging biotechs (cell and gene therapies, molecular diagnostics) and implemented incubator partnership framework NA/WEU (startup incentive)
• Developed and launched digital customer collaboration portal to ~200 Dx manufacturers redefining sales & customer interaction model for supply of critical raw materials (ongoing)
• Created market positioning for emerging biotechs (cell and gene therapies, molecular diagnostics) and implemented incubator partnership framework NA/WEU (startup incentive)
MILLIPORESIGMA (Life Science Division of Merck KGaA, Germany)
Product Management / Strategy
Head of New Business Initiatives (RNA) and Cell & Recomb Tech Franchise
1/2014 - 1/2016
• Managed team of 8 (4 directs) PMs to stabilize global portfolio (>$40M, >5k SKUs) covering stem cell, molecular biology, cell-based assay products in addition to driving NBI
• Orchestrated NBI pivots by launching new product variations combined with in-field GTM pilot to drive new technology adoption (3x increase in repeat purchase)
• Negotiated agreements with licensors, suppliers, and internal operations to more favorable terms (e.g., releasing financial pressure and extend runway for technology adoption)
• Orchestrated NBI pivots by launching new product variations combined with in-field GTM pilot to drive new technology adoption (3x increase in repeat purchase)
• Negotiated agreements with licensors, suppliers, and internal operations to more favorable terms (e.g., releasing financial pressure and extend runway for technology adoption)
MILLIPORESIGMA (Life Science Division of Merck KGaA, Germany)
Corporate Strategy & Development
Senior Manager – Strategy & Market Analytics
1/2011 - 1/2014
• Led strategic initiatives and provided strategic planning & transaction support for Bioscience BU
• Led integration of emerging microfluidic platform company including coordination of stakeholders across support, business, operational, and commercial functions to achieve target objectives
• Led integration of emerging microfluidic platform company including coordination of stakeholders across support, business, operational, and commercial functions to achieve target objectives
LEK Consulting
Management Consulting
Senior Consultant – Life Sciences
1/2006 - 1/2011
• Project leader managing teams of 3-6 associates/consultants responsible for all aspects of engagements from client and case team management to quality and accuracy of deliverables
• 40+ client engagements across the life sciences (tools, biopharma, med device) covering corporate/product/commercial strategy development, M&A screening and due diligence, product and company valuation; example engagements:
– Market opportunity definition and company valuation supporting Series
● fundraise (>$40M) for next generation sequencing technology and service provider
– Menu expansion strategy for venture-backed multiplexed molecular diagnostics provider
– 5-year growth strategy for leading flow cytometry supplier including target screening and profiling for clinical and applied market entry; resulted in $200MM+ acquisition
– Commercial due diligence for $8B merger of leading life science reagent & instrument suppliers
– Go-to-market strategy (market segmentation, value proposition, sales f
• 40+ client engagements across the life sciences (tools, biopharma, med device) covering corporate/product/commercial strategy development, M&A screening and due diligence, product and company valuation; example engagements:
– Market opportunity definition and company valuation supporting Series
● fundraise (>$40M) for next generation sequencing technology and service provider
– Menu expansion strategy for venture-backed multiplexed molecular diagnostics provider
– 5-year growth strategy for leading flow cytometry supplier including target screening and profiling for clinical and applied market entry; resulted in $200MM+ acquisition
– Commercial due diligence for $8B merger of leading life science reagent & instrument suppliers
– Go-to-market strategy (market segmentation, value proposition, sales f